{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:18:34Z","timestamp":1787498314351,"version":"build-2736575974"},"reference-count":142,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Irritable bowel syndrome (IBS) is a condition that significantly impacts the lifestyle, health, and habits of numerous individuals worldwide. Its diagnosis and classification are based on the Rome criteria, updated periodically to reflect new research findings in this field. IBS can be classified into different types based on symptoms, each with distinct treatment approaches and some differences in their pathophysiology. The exact pathological background of IBS remains unclear, with many aspects still unknown. Recent research developments suggest that disorders in the brain-gut\u2013microbiota axis are key contributors to the symptoms and severity of IBS. The central nervous system (CNS) interacts bidirectionally with intestinal processes within the lumen and the intestinal wall, with the autonomic nervous system, particularly the vagus nerve, playing an important role. However, the enteric nervous system (ENS) is also crucial in the pathophysiological pathway of IBS. The apeline\u2013corticotropin-releasing factor (CRF)\u2013toll-like receptor 4 (TLR4) signaling route via enteric glia and serotonin production in enteroendocrine cells at the enteric barrier are among the most well-understood new findings that affect IBS through the ENS. Additionally, the microbiota regulates neuronal signals, modifying enteric function by altering the number of enteric bacteria and other mechanisms. Given the limited therapeutic options currently available, it is essential to identify new treatment targets, with the brain-gut axis, particularly the enteric nervous system, being a promising focus. This study aims to delineate the molecular mechanisms that induce IBS and to suggest potential targets for future research and treatment of this potentially debilitating disease.<\/jats:p>","DOI":"10.3390\/microorganisms12102036","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T06:30:03Z","timestamp":1728455403000},"page":"2036","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7790-7845","authenticated-orcid":false,"given":"Ploutarchos","family":"Pastras","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4489-1485","authenticated-orcid":false,"given":"Ioanna","family":"Aggeletopoulou","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-8209","authenticated-orcid":false,"given":"Christos","family":"Triantos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"864721","DOI":"10.3389\/fpubh.2022.864721","article-title":"The Prevalence of Irritable Bowel Syndrome Among Chinese University Students: A Systematic Review and Meta-Analysis","volume":"10","author":"Yang","year":"2022","journal-title":"Front Public Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/gutjnl-2022-328515","article-title":"Irritable bowel syndrome: Treatment based on pathophysiology and biomarkers","volume":"72","author":"Camilleri","year":"2023","journal-title":"Gut"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3748\/wjg.v29.i26.4120","article-title":"Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment","volume":"29","author":"Huang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","article-title":"The Brain-Gut-Microbiome Axis","volume":"6","author":"Martin","year":"2018","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The Microbiota-Gut-Brain Axis: From Motility to Mood","volume":"160","author":"Margolis","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1056\/NEJMra1607547","article-title":"Irritable Bowel Syndrome","volume":"376","author":"Ford","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel Disorders","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14309\/ajg.0000000000000946","article-title":"Symptom Stability in Rome IV vs. Rome III Irritable Bowel Syndrome","volume":"116","author":"Barberio","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/apt.12573","article-title":"Characteristics of functional bowel disorder patients: A cross-sectional survey using the Rome III criteria","volume":"39","author":"Ford","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"h701","DOI":"10.1136\/bmj.h701","article-title":"Irritable bowel syndrome in adults in primary care: Summary of updated NICE guidance","volume":"350","author":"Hookway","year":"2015","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/gutjnl-2020-322519","article-title":"Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care","volume":"70","author":"Black","year":"2021","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2019.12.021","article-title":"Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom","volume":"158","author":"Palsson","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: A systematic review and meta-analysis","volume":"5","author":"Oka","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cgh.2019.05.037","article-title":"Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs. Rome III Criteria","volume":"18","author":"Black","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41395-018-0074-z","article-title":"How the Change in IBS Criteria from Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors","volume":"113","author":"Aziz","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1136\/gutjnl-2019-318308","article-title":"Role of brain imaging in disorders of brain-gut interaction: A Rome Working Team Report","volume":"68","author":"Mayer","year":"2019","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-0897-4_6","article-title":"The brain-gut axis in health and disease","volume":"817","author":"Aziz","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cercor\/10.3.206","article-title":"The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans","volume":"10","author":"Price","year":"2000","journal-title":"Cereb. Cortex"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(08)61855-5","article-title":"The emotional motor system","volume":"107","author":"Holstege","year":"1996","journal-title":"Prog. Brain Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.47.6.861","article-title":"The neurobiology of stress and gastrointestinal disease","volume":"47","author":"Mayer","year":"2000","journal-title":"Gut"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.2174\/138161206778743637","article-title":"CRF1 receptors as a therapeutic target for irritable bowel syndrome","volume":"12","author":"Martinez","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1023\/A:1005487821063","article-title":"Role of anger in antral motor activity in irritable bowel syndrome","volume":"45","author":"Welgan","year":"2000","journal-title":"Dig. Dis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/0016-5085(88)90006-6","article-title":"Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome","volume":"94","author":"Welgan","year":"1988","journal-title":"Gastroenterology"},{"key":"ref_29","first-page":"2","article-title":"The adrenergic innervation of the gastrointestinal tract","volume":"69","author":"Furness","year":"1974","journal-title":"Ergeb. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2982.2008.01094.x","article-title":"The enteric nervous system: Normal functions and enteric neuropathies","volume":"20","author":"Furness","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"J\u00e4nig, W. (2022). The Integrative Action of the Autonomic Nervous System: Neurobiology of Homeostasis, Cambridge University Press.","DOI":"10.1017\/9781108778411"},{"key":"ref_32","first-page":"595","article-title":"The sympathetic nerve\u2014An integrative interface between two supersystems: The brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrgastro.2009.35","article-title":"Principles and clinical implications of the brain-gut-enteric microbiota axis","volume":"6","author":"Rhee","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00441-010-1050-0","article-title":"Stress at the intestinal surface: Catecholamines and mucosa-bacteria interactions","volume":"343","author":"Lyte","year":"2011","journal-title":"Cell Tissue Res."},{"key":"ref_35","first-page":"G377","article-title":"Intracisternal injection of a TRH analogue stimulates gastric luminal serotonin release in rats","volume":"256","author":"Stephens","year":"1989","journal-title":"Am. J. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbi.2005.03.015","article-title":"The cholinergic anti-inflammatory pathway","volume":"19","author":"Pavlov","year":"2005","journal-title":"Brain Behav. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5056\/jnm21079","article-title":"Functional Neuroimaging in Irritable Bowel Syndrome: A Systematic Review Highlights Common Brain Alterations with Functional Movement Disorders","volume":"28","author":"Rossi","year":"2022","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e14027","DOI":"10.1111\/nmo.14027","article-title":"Association between pain sensitivity and gray matter properties in the sensorimotor network in women with irritable bowel syndrome","volume":"33","author":"Grinsvall","year":"2021","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/gast.2002.35990","article-title":"Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron","volume":"123","author":"Berman","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/gut.2004.047423","article-title":"Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome","volume":"54","author":"Morgan","year":"2005","journal-title":"Gut"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.brat.2005.05.002","article-title":"Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety","volume":"44","author":"Lackner","year":"2006","journal-title":"Behav. Res. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/nmo.12512","article-title":"Autonomic nervous system dysregulation in irritable bowel syndrome","volume":"27","author":"Salvioli","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bonaz, B., Bazin, T., and Pellissier, S. (2018). The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00049"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e13234","DOI":"10.1111\/nmo.13234","article-title":"The first brain: Species comparisons and evolutionary implications for the enteric and central nervous systems","volume":"30","author":"Furness","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1152\/physrev.00018.2022","article-title":"The enteric nervous system","volume":"103","author":"Sharkey","year":"2023","journal-title":"Physiol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOG.0b013e3282f56125","article-title":"Enteric nervous system: Reflexes, pattern generators and motility","volume":"24","author":"Wood","year":"2008","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jphs.2021.04.001","article-title":"EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome","volume":"146","author":"Nozu","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ejp.1534","article-title":"Blockade of BDNF signalling attenuates chronic visceral hypersensitivity in an IBS-like rat model","volume":"24","author":"Fan","year":"2020","journal-title":"Eur. J. Pain."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"eabg3459","DOI":"10.1126\/scitranslmed.abg3459","article-title":"Toll-like receptor 4-mediated enteric glia loss is critical for the development of necrotizing enterocolitis","volume":"13","author":"Kovler","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/j.gastro.2012.06.034","article-title":"Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling","volume":"143","author":"Anitha","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Caputi, V., Marsilio, I., Cerantola, S., Roozfarakh, M., Lante, I., Galuppini, F., Rugge, M., Napoli, E., Giulivi, C., and Orso, G. (2017). Toll-Like Receptor 4 Modulates Small Intestine Neuromuscular Function through Nitrergic and Purinergic Pathways. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00350"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00535-015-1086-8","article-title":"Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome","volume":"50","author":"Nozu","year":"2015","journal-title":"J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00535-016-1208-y","article-title":"Lipopolysaccharide induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats","volume":"52","author":"Nozu","year":"2017","journal-title":"J. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"102248","DOI":"10.1016\/j.npep.2022.102248","article-title":"Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model","volume":"94","author":"Nozu","year":"2022","journal-title":"Neuropeptides"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"G198","DOI":"10.1152\/ajpgi.00392.2006","article-title":"Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability","volume":"293","author":"Gareau","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"G254","DOI":"10.1152\/ajpgi.00186.2019","article-title":"Acute regulation of intestinal ion transport and permeability in response to luminal nutrients: The role of the enteric nervous system","volume":"318","author":"Cavin","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/nmo.12670","article-title":"Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome","volume":"27","author":"Dlugosz","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3892\/ijmm.2017.3096","article-title":"Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review)","volume":"40","author":"Mazzawi","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0047-6374(98)00154-7","article-title":"Ageing and endocrine cells of human duodenum","volume":"108","year":"1999","journal-title":"Mech. Ageing Dev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.coph.2013.09.008","article-title":"Gut microbiota, enteroendocrine functions and metabolism","volume":"13","author":"Cani","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1172\/JCI78361","article-title":"Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells","volume":"125","author":"Shahid","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-neuro-091619-022657","article-title":"Neuropod Cells: The Emerging Biology of Gut-Brain Sensory Transduction","volume":"43","author":"Kaelberer","year":"2020","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.autneu.2009.08.002","article-title":"Serotonin release and uptake in the gastrointestinal tract","volume":"153","author":"Bertrand","year":"2010","journal-title":"Auton. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: From basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2020.06.022","article-title":"RNA Sensing by Gut Piezo1 Is Essential for Systemic Serotonin Synthesis","volume":"182","author":"Sugisawa","year":"2020","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e00541","DOI":"10.14309\/ctg.0000000000000541","article-title":"Associations of Fecal Short Chain Fatty Acids with Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome","volume":"14","author":"Waseem","year":"2023","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2982.2007.00943.x","article-title":"Sigmoid-colonic motility in health and irritable bowel syndrome: A role for 5-hydroxytryptamine","volume":"19","author":"Houghton","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cgh.2008.02.060","article-title":"Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome","volume":"6","author":"Camilleri","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ajg.2012.5","article-title":"Colonic transit time and IBS symptoms: What\u2019s the link?","volume":"107","author":"Sadik","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/ajg.2009.251","article-title":"Bloating and distension in irritable bowel syndrome: The role of gastrointestinal transit","volume":"104","author":"Agrawal","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2982.2007.01025.x","article-title":"Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre","volume":"20","author":"Sadik","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/gut.2007.119446","article-title":"Guidelines on the irritable bowel syndrome: Mechanisms and practical management","volume":"56","author":"Spiller","year":"2007","journal-title":"Gut"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e14482","DOI":"10.1111\/nmo.14482","article-title":"Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome","volume":"35","author":"Algera","year":"2023","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000356314","article-title":"Motility abnormalities in irritable bowel syndrome","volume":"89","author":"DuPont","year":"2014","journal-title":"Digestion"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101973","DOI":"10.1016\/j.npep.2019.101973","article-title":"Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS)","volume":"79","author":"Hatlebakk","year":"2020","journal-title":"Neuropeptides"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e14339","DOI":"10.1111\/nmo.14339","article-title":"Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome","volume":"34","author":"Hasler","year":"2022","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpain.2022.10.007","article-title":"Spinal CircKcnk9 Regulates Chronic Visceral Hypersensitivity of Irritable Bowel Syndrome","volume":"24","author":"Chen","year":"2023","journal-title":"J. Pain"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17474124.2021.1829469","article-title":"Dilemma in post-IBD patients with IBS-D symptoms: A 2020 overview","volume":"15","author":"Tozlu","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1073\/pnas.1720017115","article-title":"Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks","volume":"115","author":"Grasset","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2014.12.037","article-title":"Microbiota controls the homeostasis of glial cells in the gut lamina propria","volume":"85","author":"Kabouridis","year":"2015","journal-title":"Neuron"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/nmo.12534","article-title":"The gut microbiome restores intrinsic and extrinsic nerve function in germ-free mice accompanied by changes in calbindin","volume":"27","author":"Mao","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/nmo.12049","article-title":"The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse","volume":"25","author":"Mao","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2982.2009.01384.x","article-title":"Lactobacillus reuteri ingestion and IK(Ca) channel blockade have similar effects on rat colon motility and myenteric neurones","volume":"22","author":"Wang","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrgastro.2016.200","article-title":"Gut-brain axis in 2016: Brain-gut-microbiota axis\u2014Mood, metabolism and behaviour","volume":"14","author":"Dinan","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/PSY.0000000000000519","article-title":"Brain-Gut-Microbiota Axis and Mental Health","volume":"79","author":"Dinan","year":"2017","journal-title":"Psychosom. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.abd6176","article-title":"Microbiota-modulated CART(+) enteric neurons autonomously regulate blood glucose","volume":"370","author":"Muller","year":"2020","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cell.2020.08.003","article-title":"The Human and Mouse Enteric Nervous System at Single-Cell Resolution","volume":"182","author":"Drokhlyansky","year":"2020","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","article-title":"Molecular Architecture of the Mouse Nervous System","volume":"174","author":"Zeisel","year":"2018","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2063016","DOI":"10.1080\/19490976.2022.2063016","article-title":"Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome","volume":"14","author":"Mujagic","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_92","first-page":"377","article-title":"Microbiota and the irritable bowel syndrome","volume":"67","author":"Sabo","year":"2021","journal-title":"Minerva Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Mishima, Y., and Ishihara, S. (2020). Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228664"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5009\/gnl19379","article-title":"Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients","volume":"15","author":"Lee","year":"2021","journal-title":"Gut Liver"},{"key":"ref_95","first-page":"17","article-title":"Use of broad-spectrum antibiotics and the development of irritable bowel syndrome","volume":"111","author":"Villarreal","year":"2012","journal-title":"WMJ"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","article-title":"Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis","volume":"152","author":"Klem","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"G52","DOI":"10.1152\/ajpgi.00338.2016","article-title":"Irritable bowel syndrome: A gut microbiota-related disorder?","volume":"312","author":"Bhattarai","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1365-2982.2008.01142.x","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome: Association with colon motility, bowel symptoms, and psychological distress","volume":"20","author":"Grover","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","article-title":"Local immune response to food antigens drives meal-induced abdominal pain","volume":"590","author":"Florens","year":"2021","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.gtc.2021.02.007","article-title":"Post-infection Irritable Bowel Syndrome","volume":"50","author":"Berumen","year":"2021","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2012-304042","article-title":"Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: Origin and effect of gut transit","volume":"63","author":"Tooth","year":"2014","journal-title":"Gut"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ajg.2013.152","article-title":"Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS","volume":"108","author":"Ferrier","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"ref_104","first-page":"53","article-title":"Postinfective diarrhoea and bile acid malabsorption","volume":"31","author":"Niaz","year":"1997","journal-title":"J. R. Coll. Physicians Lond."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Hong, K.B., Seo, H., Lee, J.S., and Park, Y. (2019). Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model. BMC Complement. Altern. Med., 19.","DOI":"10.1186\/s12906-019-2610-9"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2004.04.006","article-title":"Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction","volume":"127","author":"Wang","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1053\/gast.2000.20221","article-title":"Interstitial cells of cajal and inflammation-induced motor dysfunction in the mouse small intestine","volume":"119","author":"Der","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/gutjnl-2019-318717","article-title":"No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population","volume":"69","author":"Hugerth","year":"2020","journal-title":"Gut"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","article-title":"Identification of an Intestinal Microbiota Signature Associated with Severity of Irritable Bowel Syndrome","volume":"152","author":"Tap","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","article-title":"Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome","volume":"182","author":"Mars","year":"2020","journal-title":"Cell"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrgastro.2015.206","article-title":"Lessons learned--resolving the enigma of genetic factors in IBS","volume":"13","author":"Gazouli","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/nmo.12548","article-title":"A meta-analysis of immunogenetic Case-Control Association Studies in irritable bowel syndrome","volume":"27","author":"Czogalla","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Mahurkar-Joshi, S., and Chang, L. (2020). Epigenetic Mechanisms in Irritable Bowel Syndrome. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00805"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/gutjnl-2013-306464","article-title":"Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1","volume":"65","author":"Zhou","year":"2016","journal-title":"Gut"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e13985","DOI":"10.1111\/nmo.13985","article-title":"Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome","volume":"33","author":"Constante","year":"2021","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ueg2.12259","article-title":"Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility","volume":"10","author":"Savarino","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","article-title":"AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome with Constipation","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome with Diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/apt.16812","article-title":"Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome","volume":"55","author":"Wu","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","article-title":"Efficacy of a low FODMAP diet in irritable bowel syndrome: Systematic review and network meta-analysis","volume":"71","author":"Black","year":"2022","journal-title":"Gut"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.3748\/wjg.v20.i22.6759","article-title":"Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine","volume":"20","author":"Saha","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"709","DOI":"10.20452\/pamw.16067","article-title":"Recent advances in the treatment of irritable bowel syndrome","volume":"131","author":"Bonetto","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_124","first-page":"52","article-title":"Irritable bowel syndrome in adults: Symptoms, treatment and management","volume":"31","author":"Sunderland","year":"2017","journal-title":"Nurs. Stand."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2021.09.015","article-title":"A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction","volume":"162","author":"Keefer","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis","volume":"114","author":"Ford","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/gut.31.8.896","article-title":"Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome","volume":"31","author":"Prior","year":"1990","journal-title":"Gut"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0140-6736(92)90394-I","article-title":"Physiological effects of emotion: Assessment via hypnosis","volume":"340","author":"Whorwell","year":"1992","journal-title":"Lancet"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/00207144.2022.2094269","article-title":"Hypnobiome: A New, Potential Frontier of Hypnotherapy in the Treatment of Irritable Bowel Syndrome-A Narrative Review of the Literature","volume":"70","year":"2022","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00207149408409347","article-title":"Autonomic changes during hypnosis: A heart rate variability power spectrum analysis as a marker of sympatho-vagal balance","volume":"42","author":"DeBenedittis","year":"1994","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG Clinical Guideline: Management of Irritable Bowel Syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Qin, D., Tao, Q.F., Huang, S.L., Chen, M., and Zheng, H. (2022). Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.757969"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/sjg.SJG_266_20","article-title":"Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study","volume":"27","author":"Rai","year":"2021","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2019.08.026","article-title":"Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients with Irritable Bowel Syndrome","volume":"158","author":"Weerts","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.cgh.2015.01.015","article-title":"Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial","volume":"13","author":"Zheng","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11655-021-3521-4","article-title":"Treatment of Irritable Bowel Syndrome by Chinese Medicine: A Review","volume":"29","author":"Chen","year":"2023","journal-title":"Chin. J. Integr. Med."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Sun, Y.Y., Li, M., Li, Y.Y., Li, L.X., Zhai, W.Z., Wang, P., Yang, X.X., Gu, X., Song, L.J., and Li, Z. (2018). The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-21241-z"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00384-022-04261-0","article-title":"Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: A systematic review and meta-analysis of 10 RCTs","volume":"37","author":"Wang","year":"2022","journal-title":"Int. J. Color. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)","volume":"2","author":"Moayyedi","year":"2019","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"102781","DOI":"10.1016\/j.cis.2022.102781","article-title":"Encapsulation of multiple probiotics, synbiotics, or nutrabiotics for improved health effects: A review","volume":"309","author":"Gu","year":"2022","journal-title":"Adv. Colloid. Interface Sci."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"You, S., Ma, Y., Yan, B., Pei, W., Wu, Q., Ding, C., and Huang, C. (2022). The promotion mechanism of prebiotics for probiotics: A review. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1000517"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"Hatlebakk","year":"2020","journal-title":"Gut"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/10\/2036\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:09:44Z","timestamp":1760112584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/10\/2036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":142,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["microorganisms12102036"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12102036","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}